Targeted transcriptomic analysis of pancreatic adenocarcinoma in EUS-FNA samples by NanoString technology

Background: Integration of transcriptomic testing into EUS-FNA samples is a growing need for precision oncology in pancreatic ductal adenocarcinoma (PDAC). The NanoString platform is suitable for transcriptome profiling in low yield RNA samples. Methods: Inclusion of patients that underwent EUS-FNA...

Descripción completa

Detalles Bibliográficos
Autores principales: Pedrosa, L., Araujo, I. K., Cuatrecasas, M., Soy, G., López, S., Maurel, J., Sánchez-Montes, C., Montironi, C., Saurí, T., Sendino, O., Pérez, F. M., Ausania, F., Fernández-Esparrach, G., Espósito, F. M., Vaquero, E. C., Ginès, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230066/
https://www.ncbi.nlm.nih.gov/pubmed/37266332
http://dx.doi.org/10.3389/fmolb.2023.1161893

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230066/
https://www.ncbi.nlm.nih.gov/pubmed/37266332
http://dx.doi.org/10.3389/fmolb.2023.1161893

Ejemplares similares